AeroLeads people directory · profile
Ed Cable Email & Phone Number
Chief Executive Officer
at
Rallidae Therapeutics
LinkedIn matched
✓ Verified July 2026
3 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer
Location
Newark, California, United States
Who is Ed Cable? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Ed Cable is listed as Chief Executive Officer at Rallidae Therapeutics, based in Newark, California, United States. AeroLeads shows a matched LinkedIn profile for Ed Cable.
Ed Cable previously worked as Sr. Director of Research at Cymabay Therapeutics and Director/Senior Scientist II at Ferring Research Institute. Ed Cable holds Ph.D., Biochemistry from Umass Chan Medical School.
Company email context
Email format at Rallidae Therapeutics
This section adds company-level context without repeating Ed Cable's masked contact details.
Rallidae Therapeutics
Review company-level records connected to Ed Cable before choosing the right outreach path.
Profile bio
About Ed Cable
Highly experienced, intensely creative scientist and leader, with a demonstrated record of sustained success in drug discovery and academic science. Willing to try new things and test new technologies and abandon them if utility is not observed. Committed to making ethical first-in or best-in class products. Committed to teamwork where the team utilizes the strengths of diverse individuals. Recognizes weakness in organizations and points them out. Open to discussions about anything including my own weaknesses.
Current workplace
Ed Cable's current company
Company context helps verify the profile and gives searchers a useful next step.
5 roles · 33 years
Ed Cable work experience
A career timeline built from the work history available for this profile.
Sr. Director Of Research
Director/Senior Scientist Ii
Drug Discovery Pharmacology. Scientific Champion for V1a partial agonist project (see abstracts 177 http://bit.ly/1ax0dMX and 1604 http://bit.ly/19fZUX4)
2009 - May 2018
Scientific Investigator
Project Leader, Liver-targeted thyroid hormone receptor agonists Identified viable clinical candidate, MB07811 (http://1.usa.gov/1bggPZj) First in Human, October 20, 2006Worked and/or lead a variety of lipid and diabetes projects for the treatment of chronic metabolic diseasesSelected Publications from Metabasis (5 papers, 8 abstracts, 1 patent)Erion, M.D. , E.E. Cable, B.R. Ito, , H. Jiang, J.M. Fujitaki, P.D. Finn, B-H. Zhang, J. Hou, S.H. Boyer, P.D. van Poelje, and D.L. Linemeyer (2007) Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. PNAS USA 104: 15490-15495.Cable, E.E., .D. Finn, J.W. Stebbins, J. Hou, B.R. Ito, P.D. van Poelje, D.L. Linemeyer, and M.D. Erion (2009) Reduction of hepatic steatosis in rats and mice following treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 2009 Feb;49(2):407-17.
2002 - Mar 2009
Post-Doc To Assistant Professor
Research Projects Initiated:Molecular mechanisms of heme mediated mRNA instability of ALA synthase in rat and human cellsRole of non-oxidative forms of iron in hepatocyte transformationRole of trace metals in hepatocyte differentiationResearch Projects Supported:Analysis of novel antivirals against HBVUse of novel baculovirus systems for gene deliverySelected Publications from HMC (10 papers, 14 abstracts)Cable, E.E., J.R Connor and H.C. Isom (1998) Accumulation of iron by primary rat hepatocytes in long term culture: Incorporation of low concentrations of non-transferrin bound forms of iron. American Journal of Pathology 152:781-792.Cable, E.E., B.J. Kuhn and H.C. Isom (2002) Effects of modulators of protein phosphorylation on heme metabolism in human hepatic cells: Induction of delta-aminolevulinic synthase mRNA and protein by okadaic acid. DNA Cell Biology 21:323-332.
1994 - 2002
~8 yrs
3 education records
Ed Cable education
Ph.D., Biochemistry
Umass Chan Medical School
Biochemistry Ph.D. Program
Emory University
B.S., Chemistry
Grove City College
FAQ
Frequently asked questions about Ed Cable
Quick answers generated from the profile data available on this page.
What company does Ed Cable work for?
Ed Cable works for Rallidae Therapeutics.
What is Ed Cable's role at Rallidae Therapeutics?
Ed Cable is listed as Chief Executive Officer at Rallidae Therapeutics.
Where is Ed Cable based?
Ed Cable is based in Newark, California, United States while working with Rallidae Therapeutics.
What companies has Ed Cable worked for?
Ed Cable has worked for Rallidae Therapeutics, Cymabay Therapeutics, Ferring Research Institute, Metabasis Therapeutics, and Hershey Medical Center.
How can I contact Ed Cable?
You can use AeroLeads to view verified contact signals for Ed Cable at Rallidae Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Ed Cable attend?
Ed Cable holds Ph.D., Biochemistry from Umass Chan Medical School.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial